News from vivus, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

May 03, 2010, 07:00 ET

VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer

VIVUS, Inc. (Nasdaq: VVUS) today announced the appointment of Michael P. Miller to the position of senior vice president and chief commercial...

Apr 29, 2010, 07:00 ET

VIVUS To Present at Deutsche Bank 35th Annual Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Deutsche...

Apr 28, 2010, 07:00 ET

Data on VIVUS' Qnexa To Be Featured at the American Society of Hypertension Annual Meeting

VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa®, an investigational drug candidate, will be presented at the American Society...

Apr 01, 2010, 08:00 ET

VIVUS to Present at the 2010 Future Leaders in the Biotech Industry Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at BioCentury's...

Mar 31, 2010, 08:00 ET

VIVUS Announces Termination of Agreement for the Development of Testosterone MDTS(R)

VIVUS, Inc. (Nasdaq: VVUS) today announced that it has terminated the Development and Commercialization Agreement with FemPharm Pty Ltd. (a wholly...

Mar 26, 2010, 07:00 ET

VIVUS Announces Date of FDA Advisory Committee Review of Qnexa(R) for the Treatment of Obesity

VIVUS, Inc. (Nasdaq: VVUS) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration...

Mar 19, 2010, 08:59 ET

VIVUS to Present at Barclays Capital 2010 Global Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Barclays...

Mar 08, 2010, 16:01 ET

VIVUS Reports 2009 Fourth Quarter and Full-Year Financial Results

VIVUS, Inc. (Nasdaq: VVUS) today reported its financial results for the fourth quarter and year ended December 31, 2009. "This past year was...

Mar 08, 2010, 07:00 ET

VIVUS Announces the Issuances of Three Additional Qnexa(R) Patents

VIVUS, Inc. (Nasdaq: VVUS) today announced the issuance of three additional patents by the U.S. Patent and Trademark Office (USPTO) covering Qnexa,...

Mar 03, 2010, 08:26 ET

VIVUS to Present at Two Upcoming Investor Conferences

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, Chief Financial Officer, will present an overview of the company at two investment...

Mar 01, 2010, 07:00 ET

VIVUS Announces FDA Acceptance of Qnexa(R) New Drug Application for Treatment of Obesity

VIVUS, Inc. (Nasdaq: VVUS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the company's new drug...

Feb 04, 2010, 07:00 ET

VIVUS to Present at the BIO CEO and Investor Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Dr. Charles Bowden, senior director, clinical development, will present an overview of the company...

Jan 11, 2010, 07:00 ET

VIVUS Announces Additional Results of Phase 3 avanafil Study in Erectile Dysfunction Showing Efficacy in 15 Minutes

VIVUS, Inc. (Nasdaq: VVUS) today announced new data from an analysis of the recently completed phase 3 study (REVIVE TA-301) of avanafil,...

Jan 07, 2010, 07:00 ET

VIVUS Announces Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea

VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from a phase 2 study evaluating the safety and efficacy of Qnexa®, an...

Jan 06, 2010, 16:26 ET

VIVUS To Host Conference Call and Webcast Discussion of Results From Phase 2 Study of Qnexa(R) in Obstructive Sleep Apnea

VIVUS, Inc. (Nasdaq: VVUS) plans to announce the results from a phase 2 study evaluating the safety and efficacy of Qnexa, for the treatment of...

Jan 05, 2010, 07:00 ET

VIVUS to Present at the 2010 JP Morgan Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Leland Wilson, chief executive officer, will present an overview of the company at the 28th...

Dec 29, 2009, 07:00 ET

VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity

VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in...

Nov 18, 2009, 06:30 ET

VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction; Data Demonstrate Robust Efficacy, Favorable Side-Effect Profile

VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from REVIVE (TA-301), a phase 3 pivotal study evaluating the safety and efficacy of...

Nov 17, 2009, 16:01 ET

VIVUS to Host Conference Call and Webcast Discussion of Avanafil Phase 3 Results

VIVUS, Inc. (Nasdaq: VVUS) plans to announce the results from the avanafil REVIVE (TA-301) phase 3 clinical trial on November 18th prior to...

Nov 11, 2009, 07:00 ET

VIVUS to Present at Lazard Capital Markets Healthcare Conference

VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Lazard...